SELECT id, `name`, primary_key, `key`, treemapgroup, name_cn, zacks_table_name, compare_key, compare_display_name from gurufocu_main.financial_definition where termpagedisplay=1 and `key` = 'change_in_organic_revenue_pct' WST (West Pharmaceutical Services) Change in Organic Revenu
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » West Pharmaceutical Services Inc (NYSE:WST) » Definitions » Change in Organic Revenue %

West Pharmaceutical Services (West Pharmaceutical Services) Change in Organic Revenue %

: 1.40% (As of Dec. 2023)
View and export this data going back to 1980. Start your Free Trial

Organic revenue is revenue generated from within a company that is a direct result of the firm's existing operations. Change in Organic Revenue % provides management and investors with the level of revenue change that was generated from the sale of a company's products and services.

West Pharmaceutical Services's Change in Organic Revenue % for the quarter that ended in Dec. 2023 was 1.40% , which is lower than 5.70% for the pervious quarter ended in Sep. 2023.

West Pharmaceutical Services's Change in Organic Revenue % for the annual that ended in Dec. 2023 was 1.60% , which is lower than 7.70% for the pervious year ended in Dec. 2022.

The historical rank and industry rank for West Pharmaceutical Services's Change in Organic Revenue % or its related term are showing as below:

WST's Change in Organic Revenue % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median:
* Ranked among companies with meaningful Change in Organic Revenue % only.

West Pharmaceutical Services Change in Organic Revenue % Historical Data

The historical data trend for West Pharmaceutical Services's Change in Organic Revenue % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

West Pharmaceutical Services Annual Data
Trend Dec21 Dec22 Dec23
Change in Organic Revenue %
Premium Member Only Premium Member Only Premium Member Only

West Pharmaceutical ServicesQuarterly Data
Trend Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Change in Organic Revenue %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only

Competitive Comparison

For the Medical Instruments & Supplies subindustry, West Pharmaceutical Services's Change in Organic Revenue %, along with its competitors' market caps and Change in Organic Revenue % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


West Pharmaceutical Services  (NYSE:WST) Change in Organic Revenue % Explanation

Organic revenue is the product of the internal processes of a company and are generated solely within the firm minus cost of goods sold (COGS). It’s similar to the gross income. Organic revenue provides management and investors with the level of revenue that was generated from the sale of a company's products and services.

If the change in organic revenue is positive, then the company generates increases in organic revenue, which is typically referred to as organic growth. Once an acquisition is fully integrated into a company's existing operations, sales from the acquired unit or business would then be counted as organic sales.

Organic revenue is important because it doesn't include taxes and other one-off items that may skew a company's profit in a given year. The changing of the organic revenue also reflects the company’s core business profitability is increasing, especially when an acquisition happened. It is a more reliable index than gross income at that time because the performance of newly acquired businesses may change in the future.


West Pharmaceutical Services (West Pharmaceutical Services) Business Description

Traded in Other Exchanges
Address
530 Herman O. West Drive, Exton, PA, USA, 19341-0645
West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States.
Executives
Chad Winters officer: VP, CAO & Controller 530 HERMAN O. WEST DRIVE, EXTON PA 19341
Charles Witherspoon officer: VP & Treasurer 530 HERMAN O WEST DRIVE, EXTON PA 19341
Annette F Favorite officer: Sr. VP Human Resources Officer 530 HERMAN O. WEST DRIVE, EXTON PA 19341
Cindy Reiss-clark officer: Senior Vice President 530 HERMAN O. WEST DRIVE, EXTON PA 19341-1147
Quintin J Lai officer: VP Corp Development & Strategy 530 HERMAN 0. WEST DRIVE, EXTON PA 19341
Silji Abraham officer: Chief Digital & Trans Officer 5000 TOWN CENTER, U, SOUTHFIELD MI 48075
Eric Mark Green officer: Chief Executive Officer 530 HERMAN O. WEST DRIVE, EXTON PA 19341
Bernard Birkett officer: Sr VP, CFO & Treasurer 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Thomas W Hofmann director FIVE RADNOR CORPORATE CENTER, SUITE 500, RADNOR PA 19087
Stephen H Lockhart director C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Molly Joseph director 9209 GRAND SUMMIT BLVD, DRIPPING SPRINGS TX 78620
Kimberly Banks Mackay officer: SVP, GC & Corporate Secretary 530 HERMAN O. WEST DRIVE, EXTON PA 19341
George Lloyd Miller officer: Sr. VP, GC & Corp. Sec. 530 HERMAN O. WEST DRIVE, EXTON PA 19341
David A Montecalvo officer: SVP, Glob Ops and Supply Chain 530 HERMAN O. WEST DRIVE, EXTON PA 19341
Robert F Friel director 940 WINTER STREET, WALTHAM MA 02451